Market Cap 449.89M
Revenue (ttm) 3.93M
Net Income (ttm) -126.24M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,212.21%
Debt to Equity Ratio 0.00
Volume 1,427,700
Avg Vol 1,660,804
Day's Range N/A - N/A
Shares Out 294.04M
Stochastic %K 93%
Beta 1.70
Analysts Sell
Price Target $6.00

Latest News on PGEN

Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript

Mar 19, 2025, 7:47 PM EDT - 5 weeks ago

Precigen, Inc. (PGEN) Q4 2024 Earnings Call Transcript


Precigen to Participate in the Stifel 2024 Healthcare Conference

Nov 12, 2024, 4:05 PM EST - 5 months ago

Precigen to Participate in the Stifel 2024 Healthcare Conference


Precigen, Inc. (PGEN) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 7:03 PM EDT - 9 months ago

Precigen, Inc. (PGEN) Q2 2024 Earnings Call Transcript


Actym Therapeutics Appoints Thomas Smart as CEO

Apr 24, 2024, 9:00 AM EDT - 1 year ago

Actym Therapeutics Appoints Thomas Smart as CEO

ANAB XOMA


Precigen, Inc. (PGEN) Q4 2023 Earnings Call Transcript

Mar 19, 2024, 8:49 PM EDT - 1 year ago

Precigen, Inc. (PGEN) Q4 2023 Earnings Call Transcript


Precigen: RRP Targeting With AdenoVerse Technology Platform

Jan 19, 2024, 7:39 PM EST - 1 year ago

Precigen: RRP Targeting With AdenoVerse Technology Platform


Precigen, Inc. (PGEN) Q2 2023 Earnings Call Transcript

Aug 9, 2023, 3:03 PM EDT - 1 year ago

Precigen, Inc. (PGEN) Q2 2023 Earnings Call Transcript